Plain-English translation of NCT07646587 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called given as an injection to see if it is safe and effective for people with moderate to severe chronic obstructive pulmonary disease (COPD). You would continue taking your current COPD medications while also receiving either the new treatment or a placebo injection. The study will last 24 weeks and will help doctors understand how the medication works in your body and whether it helps improve your condition.
People with moderate to severe COPD often struggle even when on current standard treatments, and doctors are looking for new options to help reduce symptoms and improve quality of life. This medication is being tested to see if it could offer additional benefit to patients like you who already use multiple inhalers.
You likely qualify if…
You likely don't qualify if…
You would visit the study center for a screening visit to confirm you qualify, then return for regular visits over 24 weeks to receive either injections or placebo injections (you won't know which). During these visits, doctors will monitor your breathing, check your blood work, and ask how you're feeling. You'll continue taking all your regular COPD medications throughout the study.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States